Impact of HER2-targeted PET/CT imaging in patients with breast cancer and therapeutic response monitoring.

Oncologist · 2025 · PMC11783325 · PMID 39083323

Europe PMC DOI

hedged sentence

0.3020

closest p · 6.0× alpha

0.3020

boldest claim

The sentences

did not reach statistical significanceP = .302not close (p > 0.1)

While the SUVmax values in HER2-targeted PET/CT imaging for patients achieving pCR exhibited a higher trend compared to those with PR, this difference did not reach statistical significance ( P = .302; Figure 4A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.